Logo image
Sign in
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis
Journal article   Peer reviewed

Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis

Bradley J. Monk, Thomas J. Herzog, Stanley B. Kaye, Carolyn N. Krasner, Jan B. Vermorken, Franco M. Muggia, Eric Pujade-Lauraine, Youn C. Park, Trilok V. Parekh and Andres M. Poveda
European Journal of Cancer, Vol.48(15), pp.2361-2368
2012
PMID: 22541893

Details